Latest Breaking News On - நாற்பது ஏழு - Page 1 : comparemela.com
Cancer Monoclonal Antibodies Global Market Report 2021:
globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.
Iranian Film Festival at Online - Virtual Event in San Francisco - September 18, 2021
sfstation.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sfstation.com Daily Mail and Mail on Sunday newspapers.
7 Wide-Moat Stocks in Healthcare to Buy
morningstar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from morningstar.com Daily Mail and Mail on Sunday newspapers.
$5,000 Invested in These 3 Healthcare Stocks Could Make You Rich Over the Next 10 Years
fool.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fool.com Daily Mail and Mail on Sunday newspapers.
IGM Biosciences Announces the Appointment of Chris H. Takimoto, M.D., Ph.D., F.A.C.P., as Chief Medical Officer
MOUNTAIN VIEW, Calif., July 29, 2021 (GLOBE NEWSWIRE) IGM Biosciences, Inc. (Nasdaq: IGMS), a clinical-stage biotechnology company focused on creating and developing engineered IgM antibodies, today announced the appointment of Chris H. Takimoto, M.D., Ph.D., F.A.C.P., to the role of Chief Medical Officer, effective today. Dr. Takimoto will be responsible for global development of IGM’s clinical pipeline of proprietary IgM antibodies. He joins IGM with 30 years of experience in cancer research and development, most recently as Senior Vice President, Oncology, Gilead Sciences, Inc. Daniel S. Chen, M.D., Ph.D., will continue to assist the Company in a consulting capacity.